tradingkey.logo

tradingkey.logo
怜玢


Codexis Inc

CDXS
りォッチリストに远加
1.370USD
-0.010-0.72%
終倀 09-23 16:00ET
147.36M時䟡総額
損倱額盎近12ヶ月PER

Codexis Incに぀いお 䌁業名

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Inc プロフィヌル


䌁業コヌドCDXS
䌚瀟名Codexis Inc
䞊堎日Apr 22, 2010
最高経営責任者「CEO」Moore (Alison)
埓業員数188
蚌刞皮類Ordinary Share
決算期末Apr 22
本瀟所圚地200 Penobscot Dr
郜垂REDWOOD CITY
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94063
電話番号16504218100
りェブサむトhttps://www.codexis.com/
䌁業コヌドCDXS
䞊堎日Apr 22, 2010
最高経営責任者「CEO」Moore (Alison)

Codexis Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--

よくある質問

Codexis Incの䞊䜍5名の株䞻は誰ですか


Codexis Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Alison Moore, Ph.D.

Codexis IncCDXSの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Codexis Incの株匏を保有しおいる機関は273瀟あり、保有株匏の総垂堎䟡倀は玄66.34Mで、党䜓の73.00%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-13883230.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。